Mortality due to non-cardiovascular causes did not appear to be elevated in the subgroup of the cohort with high VEGF-A levels, as might be expected due to the role of VEGF-A in tumour angiogenesis [46]. This evidence concerns the gene VEGFA and neoplasm.